奥麦罗制药 OMER 深 沪
已收盘 08-15 16:00:00 美东时间
4.41
+0.290
+7.04%
华盛通- 最 高4.54
- 今 开4.23
- 成交量 267.89万股
- 最 低 4.15
- 昨 收 4.12
- 总市值 2.58亿
- 52周最高 13.60
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.95
- 委 比 63.21%
- 总股本 5859.27万
- 历史最高 30.23
- 量 比 3.03
- 振 幅 9.47%
- 历史最低 0.92
- 每 手 1
- 风险率 2.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多D. Boral Capital Maintains Buy on Omeros, Maintains $36 Price Target
D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.
08-15 19:11
Needham Reiterates Hold on Omerosto Hold
Needham analyst Serge Belanger reiterates Omeros (NASDAQ:OMER) from Hold to Hold.
08-15 18:02
Omeros Q2 EPS $(0.43) Beats $(0.52) Estimate
Omeros (NASDAQ:OMER) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.52) by 17.78 percent. This is a 55.67 percent increase over losses of $(0.97) per share from the same
08-15 04:03
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Earnings Preview: Omeros
Omeros (NASDAQ:OMER) is set to give its latest quarterly earnings report on Thu...
08-14 02:02
21.55亿，这家抗生素企业被收购！
（来源：动脉新医药） 当地时间8月7日，生物制药公司CorMedix Inc. (NASDAQ:CRMD)和新型抗生素企业Melinta Therapeuti...
08-08 18:11
Somnigroup International's CorMedix to Acquire Melinta in $300M Deal, Expanding Infectious Disease Portfolio
CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, and Melinta Therapeutics LLC ("Melinta"),
08-07 19:14
ALLEGIANT TRAVEL COMPANY SECOND QUARTER 2025 FINANCIAL RESULTS
Second quarter 2025 GAAP diluted loss per share of $(3.62) Second quarter 2025 adjusted airline-only diluted earnings per share of $1.86(1)(2) Second quarter 2025 adjusted diluted earnings p...
08-05 04:01
Omeros rises after pricing ~$22M stock offering
Omeros (NASDAQ:OMER) has entered into a securities purchase agreement with Polar Asset Management Partners to sell ~$22 million of its common stock in a registered direct offering. Under the terms of ...
07-25 20:21
Omeros Corporation Announces Pricing Of $22M Registered Direct Offering At $4.10 Per Share
Omeros Corporation (NASDAQ:OMER) ("Omeros" or the "Company") announced that on July 24, 2025 it entered into a securities purchase agreement with Polar Asset Management Partners to sell approximately $22 million of its
07-25 20:04
